Bank Of America Corp Durect Corp Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.43 - $5.9 $43 - $595	-101 Reduced 75.37%	33 $0
Q2 2022 Aug 12, 2022	BUY	$0.38 - $0.64 $1 - $2	4 Added 3.08%	134 $0
Q1 2022 May 16, 2022	SELL	$0.55 - $0.98 $40,293 - $71,794	-73,260 Reduced 99.82%	130 $0
Q4 2021 Feb 08, 2022	BUY	$0.9 - $1.31 $42,972 - $62,548	47,747 Added 186.2%	73,390 $73,000
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.61 $3,027 - $4,028	-2,502 Reduced 8.89%	25,643 $33,000
Q2 2021 Sep 13, 2021	BUY	$1.6 - $2.02 $45,032 - $56,852	28,145 New	28,145 $46,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $180M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.